| Manjinder Kaur, APN | |
|
230 E Ridgewood Ave, Paramus, NJ 07652-4142 | |
| (201) 212-3111 | |
| Not Available |
| Full Name | Manjinder Kaur |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 230 E Ridgewood Ave, Paramus, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073170973 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Bridge Medical Center | Paramus, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bergen County Improvement Authority | 9032104047 | 62 |
News Archive
The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.
The report says that due to the growing and ageing population the actual number of new cases will rise by almost 40 per cent on 2007 levels. But when that's converted to the number of cases per 100,000 people the results are surprising. Cancer rates in men will fall from 595 to 568 cases per 100,000 by 2020. That equates to about 85,000 cases. When it comes to women the rate is projected to rise from 394 to 408 cases per 100,000. That's equivalent to 65,000 new cases in 2020.
N-of-One, Inc., provider of Diagnostic Strategy Roadmaps and Treatment Strategy Roadmaps for personalized cancer care, announced today that the company has developed a unique knowledge integration platform to enable care providers and patients to make informed decisions about diagnostic and treatment strategy.
Scientists may have made a giant leap in fighting the biggest threat to human health by using supercomputing to keep pace with the impressive ability of diseases to evolve.
› Verified 4 days ago
| Entity Name | Bergen County Improvement Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891836441 PECOS PAC ID: 9032104047 Enrollment ID: O20040419001038 |
News Archive
The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.
The report says that due to the growing and ageing population the actual number of new cases will rise by almost 40 per cent on 2007 levels. But when that's converted to the number of cases per 100,000 people the results are surprising. Cancer rates in men will fall from 595 to 568 cases per 100,000 by 2020. That equates to about 85,000 cases. When it comes to women the rate is projected to rise from 394 to 408 cases per 100,000. That's equivalent to 65,000 new cases in 2020.
N-of-One, Inc., provider of Diagnostic Strategy Roadmaps and Treatment Strategy Roadmaps for personalized cancer care, announced today that the company has developed a unique knowledge integration platform to enable care providers and patients to make informed decisions about diagnostic and treatment strategy.
Scientists may have made a giant leap in fighting the biggest threat to human health by using supercomputing to keep pace with the impressive ability of diseases to evolve.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Manjinder Kaur, APN 230 E Ridgewood Ave, Paramus, NJ 07652-4142 Ph: (201) 212-3111 | Manjinder Kaur, APN 230 E Ridgewood Ave, Paramus, NJ 07652-4142 Ph: (201) 212-3111 |
News Archive
The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.
The report says that due to the growing and ageing population the actual number of new cases will rise by almost 40 per cent on 2007 levels. But when that's converted to the number of cases per 100,000 people the results are surprising. Cancer rates in men will fall from 595 to 568 cases per 100,000 by 2020. That equates to about 85,000 cases. When it comes to women the rate is projected to rise from 394 to 408 cases per 100,000. That's equivalent to 65,000 new cases in 2020.
N-of-One, Inc., provider of Diagnostic Strategy Roadmaps and Treatment Strategy Roadmaps for personalized cancer care, announced today that the company has developed a unique knowledge integration platform to enable care providers and patients to make informed decisions about diagnostic and treatment strategy.
Scientists may have made a giant leap in fighting the biggest threat to human health by using supercomputing to keep pace with the impressive ability of diseases to evolve.
› Verified 4 days ago
Yongsoon Ko, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 230 E. Ridgewood Ave, Bergen Regional Medical Center, Paramus, NJ 07652 Phone: 201-207-9557 Fax: 201-784-1136 | |
Renee Barnes, APN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 140 E Ridgewood Ave Ste 415s, Paramus, NJ 07652 Phone: 615-673-4455 Fax: 615-432-4651 | |
Mrs. Althea Doreen Brown, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 230 E Ridgewood Ave, Paramus, NJ 07652 Phone: 201-967-4000 | |
Bernard Favarato Perutti, AGPCNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 90 W Ridgewood Ave, Paramus, NJ 07652 Phone: 201-652-1950 | |
Mrs. Catherine Kim, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 300 Forest Ave, Paramus, NJ 07652 Phone: 201-490-5158 | |
Elizabeth Heydt, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Sears Dr, Paramus, NJ 07652 Phone: 201-830-2287 |